Dr. Gelmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 North Campbell St
Tucson, AZ 85724Phone+1 520-626-8096
Summary
- Edward Gelmann, MD is Professor of Medicine and hold the John Norton Chair in Prostate Cancer Research at the University of Arizona. He completed his medical education at Stanford University School of Medicine in 1976, following it up with a residency at the University of Chicago Medical Center from 1976 to 1978. He completed oncology fellowship at the NCI in Bethesda, MD, and remained at the NCI as a tenured Senior Investigator until 1988. Dr. Gelmann subsequently was a professor at Georgetown University and then at Columbia University before moving to the University of Arizona.
Education & Training
- University of Chicago Medical CenterResidency, 1976 - 1978
- Stanford University School of MedicineClass of 1976
Certifications & Licensure
- AZ State Medical License 2018 - 2026
- MD State Medical License 1978 - 2026
- NY State Medical License 2007 - 2026
- DC State Medical License 1988 - 2024
- IL State Medical License 1977 - 1987
- CA State Medical License 1978 - 1980
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 33 citationsOccurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.Edward P. Gelmann, David J. Steadman, Jing Ma, Natalie Ahronovitz, H. James Voeller
Cancer Research. 2002-05-01 - 19 citationsThe Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B KinaseLiang-Nian Song, Jose M. Silva, Antonius Koller, Andrew S. Rosenthal, Emily I. Chen
Molecular Cancer Research. 2015-05-01 - 20 citationsLoss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.Cai Bowen, Michael C. Ostrowski, Gustavo Leone, Edward P. Gelmann
Cancer Research. 2019-08-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: